Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000619484 | SCV000737708 | likely benign | Cardiovascular phenotype | 2016-09-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000631855 | SCV000752952 | likely benign | Long QT syndrome | 2024-07-10 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001526917 | SCV001737673 | benign | not specified | 2021-06-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001595027 | SCV001828967 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001595027 | SCV005208604 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV001526917 | SCV001920491 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001595027 | SCV001928469 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001595027 | SCV001971158 | likely benign | not provided | no assertion criteria provided | clinical testing |